Intact Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.15M | Sell |
14,640
-44,160
| -75% | -$3.56M | 0.03% | 193 |
|
|
2026
Q1 | $5.1M | Sell |
58,800
-34,700
| -37% | -$3.32M | 0.15% | 133 |
|
|
2025
Q4 | $8.98M | Hold |
93,500
| – | – | 0.26% | 85 |
|
|
2025
Q3 | $8.9M | Buy |
93,500
+53,300
| +133% | +$4.9M | 0.27% | 79 |
|
|
2025
Q2 | $3.5M | Buy |
40,200
+9,000
| +29% | +$763K | 0.12% | 146 |
|
|
2025
Q1 | $2.8M | Hold |
31,200
| – | – | 0.1% | 165 |
|
|
2024
Q4 | $2.49M | Sell |
31,200
-14,400
| -32% | -$1.25M | 0.09% | 169 |
|
|
2024
Q3 | $4.11M | Buy |
+45,600
| New | +$3.84M | 0.14% | 154 |
|
|
2024
Q2 | – | Sell |
-35,800
| Closed | -$3.12M | – | 286 |
|
|
2024
Q1 | $3.12M | Hold |
35,800
| – | – | 0.12% | 150 |
|
|
2023
Q4 | $2.95M | Buy |
+35,800
| New | +$2.73M | 0.12% | 156 |
|
|
2022
Q4 | – | Sell |
-64,600
| Closed | -$5.22M | – | 275 |
|
|
2022
Q3 | $5.22M | Sell |
64,600
-10,000
| -13% | -$899K | 0.17% | 105 |
|
|
2022
Q2 | $6.7M | Sell |
74,600
-20,300
| -21% | -$2.06M | 0.21% | 96 |
|
|
2022
Q1 | $10.5M | Buy |
94,900
+22,900
| +32% | +$2.42M | 0.27% | 81 |
|
|
2021
Q4 | $7.45M | Buy |
72,000
+8,800
| +14% | +$1.02M | 0.19% | 102 |
|
|
2021
Q3 | $7.92M | Buy |
63,200
+1,600
| +3% | +$207K | 0.22% | 83 |
|
|
2021
Q2 | $7.64M | Sell |
61,600
-1,000
| -2% | -$126K | 0.22% | 93 |
|
|
2021
Q1 | $7.4M | Sell |
62,600
-19,700
| -24% | -$2.31M | 0.22% | 94 |
|
|
2020
Q4 | $9.63M | Sell |
82,300
-2,100
| -2% | -$231K | 0.31% | 74 |
|
|
2020
Q3 | $8.75M | Sell |
84,400
-2,000
| -2% | -$201K | 0.3% | 68 |
|
|
2020
Q2 | $7.91M | Buy |
86,400
+11,200
| +15% | +$1.07M | 0.3% | 74 |
|
|
2020
Q1 | $6.79M | Buy |
75,200
+26,100
| +53% | +$2.78M | 0.3% | 74 |
|
|
2019
Q4 | $5.57M | Sell |
49,100
-11,700
| -19% | -$1.28M | 0.19% | 92 |
|
|
2019
Q3 | $6.6M | Sell |
60,800
-19,200
| -24% | -$2M | 0.23% | 78 |
|
|
2019
Q2 | $7.79M | Buy |
80,000
+13,400
| +20% | +$1.22M | 0.28% | 71 |
|
|
2019
Q1 | $6.07M | Buy |
66,600
+24,200
| +57% | +$2.17M | 0.22% | 86 |
|
|
2018
Q4 | $3.86M | Hold |
42,400
| – | – | 0.16% | 114 |
|
|
2018
Q3 | $4.17M | Sell |
42,400
-3,900
| -8% | -$361K | 0.15% | 117 |
|
|
2018
Q2 | $3.96M | Sell |
46,300
-78,300
| -63% | -$6.54M | 0.14% | 115 |
|
|
2018
Q1 | $9.99M | Buy |
124,600
+113,501
| +1,023% | +$9.36M | 0.39% | 52 |
|
|
2017
Q4 | $897K | Buy |
11,099
+700
| +7% | +$56.1K | 0.04% | 135 |
|
|
2017
Q3 | $808K | Sell |
10,399
-1,700
| -14% | -$141K | 0.04% | 140 |
|
|
2017
Q2 | $1.07M | Buy |
12,099
+4,300
| +55% | +$363K | 0.05% | 128 |
|
|
2017
Q1 | $628K | Sell |
7,799
-6,100
| -44% | -$476K | 0.03% | 150 |
|
|
2016
Q4 | $990K | Sell |
13,899
-1,000
| -7% | -$78.6K | 0.04% | 150 |
|
|
2016
Q3 | $1.29M | Sell |
14,899
-1,300
| -8% | -$113K | 0.05% | 135 |
|
|
2016
Q2 | $1.41M | Buy |
16,199
+1,600
| +11% | +$129K | 0.06% | 131 |
|
|
2016
Q1 | $1.09M | Buy |
14,599
+1,600
| +12% | +$121K | 0.04% | 138 |
|
|
2015
Q4 | $999K | Buy |
+12,999
| New | +$979K | 0.04% | 145 |
|
|
2014
Q4 | – | Sell |
-13,800
| Closed | -$855K | – | 266 |
|
|
2014
Q3 | $855K | Hold |
13,800
| – | – | 0.04% | 147 |
|
|
2014
Q2 | $880K | Buy |
13,800
+5,500
| +66% | +$334K | 0.04% | 125 |
|
|
2014
Q1 | $511K | Buy |
8,300
+3,100
| +60% | +$181K | 0.02% | 170 |
|
|
2013
Q4 | $298K | Buy |
5,200
+600
| +13% | +$34K | 0.01% | 200 |
|
|
2013
Q3 | $245K | Buy |
+4,600
| New | +$248K | 0.01% | 200 |
|
Other funds holding MDT
Intact Investment Management's MDT Position: Q2 2026 in Review
Intact Investment Management reduced its Medtronic (MDT) stake by 75% in Q2 2026, selling an estimated $3.56M and leaving 14,640 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #193.
Intact Investment Management first reported a position in MDT in Q3 2013 and has held it in 43 quarters since. The position peaked at $10.5M in Q1 2022. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Intact Investment Management held 14,640 shares of Medtronic worth $1.15M as of Q2 2026.
- Intact Investment Management sold 44,160 Medtronic shares in Q2 2026, an estimated $3.56M.
- Medtronic made up 0.03% of Intact Investment Management's portfolio in Q2 2026, its #193 holding.
- Intact Investment Management first reported a position in Medtronic in Q3 2013 and has held it in 43 quarters since.
- Intact Investment Management's Medtronic position peaked at $10.5M in Q1 2022.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Intact Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.